ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,021.82
      -0.28%
      US Tech 100
      16,859.60
      -0.73%
      Dow Jones
      37,943.09
      0.34%
      Brent Oil
      83.51
      -2.78%
      Bitcoin
      56,983.76
      -5.97%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Omeros Corporation (OMER)

      7. Omeros Corporation (OMER) News

      OMER

      Omeros (OMER)

      Omeros Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:OMER
      DateTimeSourceHeadlineSymbolCompany
      04/01/20244:02PMBusiness WireOmeros Corporation Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
      03/27/20248:30AMBusiness WireOmeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024NASDAQ:OMEROmeros Corporation
      02/20/20249:00AMBusiness WireOmeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic MicroangiopathyNASDAQ:OMEROmeros Corporation
      02/14/20246:05AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OMEROmeros Corporation
      02/07/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
      02/01/20249:11AMBusiness WireOmeros Corporation Announces Additional Royalty Monetization with DRI Healthcare TrustNASDAQ:OMEROmeros Corporation
      01/29/20243:26PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OMEROmeros Corporation
      11/21/20238:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
      11/17/20239:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
      11/17/20239:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
      11/17/20239:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
      11/15/20239:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
      11/09/20234:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMEROmeros Corporation
      11/09/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
      11/09/20234:02PMBusiness WireOmeros Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
      11/06/20238:00AMBusiness WireOmeros Corporation to Announce Third Quarter Financial Results on November 9, 2023NASDAQ:OMEROmeros Corporation
      11/03/20239:05AMBusiness WireOmeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic MicroangiopathyNASDAQ:OMEROmeros Corporation
      11/02/20239:05AMBusiness WireOmeros Corporation Announces Upcoming Presentations at ASH Annual MeetingNASDAQ:OMEROmeros Corporation
      10/19/20238:30AMBusiness WireOmeros Corporation Hires Andreas Grauer M.D. as Chief Medical OfficerNASDAQ:OMEROmeros Corporation
      10/16/20234:36PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
      10/16/20237:30AMBusiness WireOmeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA NephropathyNASDAQ:OMEROmeros Corporation
      09/27/20235:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
      09/27/20234:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
      09/27/20234:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
      09/20/20234:47PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OMEROmeros Corporation
      09/14/20237:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
      08/09/20235:20PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OMEROmeros Corporation
      08/09/20238:05AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMEROmeros Corporation
      08/09/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
      08/09/20238:00AMBusiness WireOmeros Corporation Reports Second Quarter 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
       Showing the most relevant articles for your search:NASDAQ:OMER